e-learning
resources
Paris 2018
Monday, 17.09.2018
Critically ill patients: prognostic factors and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of early antibiotic therapy (EAT) on outcome of patients with sepsis at the emergency room of National Kidney and Transplant Institute
I. Tan (Quezon City, Philippines), M. Mendoza (Quezon City, Philippines)
Source:
International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Session:
Critically ill patients: prognostic factors and biomarkers
Session type:
Thematic Poster
Number:
2299
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Tan (Quezon City, Philippines), M. Mendoza (Quezon City, Philippines). Impact of early antibiotic therapy (EAT) on outcome of patients with sepsis at the emergency room of National Kidney and Transplant Institute. 2299
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Management of severe acute asthma in childhood: Impact of intravenous magnesium therapy
Source: International Congress 2014 – Lung disease in neonates and beyond
Year: 2014
Outcome of treatment of TB/HIV patients in a referral center in Iran National Research Institute of Tuberculosis and Lung Disease
Source: Eur Respir J 2005; 26: Suppl. 49, 454s
Year: 2005
National homefill survey in Scotland
Source: International Congress 2014 – Best posters in physical activity, exercise testing and muscles
Year: 2014
Clinical and pharmacoeconomical assessment of sequential therapy applied in commmunity-aquired pneumonia (CAP) in Internal Medicine Department
Source: Eur Respir J 2002; 20: Suppl. 38, 357s
Year: 2002
10 years’ experience of referral of ILD patients with Suspected PH to a National PH Service: Demographics and Outcomes
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018
Advance Care Planning (ACP) for end stage respiratory patients identified using the Hospital One year Mortality Rating (HOMR) tool
Source: International Congress 2017 – Nursing practice across respiratory care pathways
Year: 2017
An audit of adherence to Two-Level Well’s Score in patients hospitalized with Sars-Co-V-2 with suspected Pulmonary Emboli in a University Hospital.
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021
Predictors of success for pulmonary rehabilitation in patients awaiting lung transplantation
Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training
Year: 2014
Triage of national early warning score(NEWS) in Pulmonary Medicine Ward at Central Chest Institute of Thailand
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
REG endpoint validation: Association between database and patient-reported exacerbations
Source: International Congress 2014 – Respiratory symptoms in primary care populations
Year: 2014
Assessment of the results of the in-hospital phase of the individualized treatment in patients with tuberculosis produced by polychimioresistant germs (MDR-TB) hospitalized in the National Institute of Pulmonology 'Marius Nasta' between 1998-2000
Source: Eur Respir J 2002; 20: Suppl. 38, 359s
Year: 2002
Imaging of empyema (EMP) in children: How bedside ultrasonography (US) impact on clinical practice?
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014
Is parenteral adrenaline used unnecessarily in the treatment of asthma patients in the pre-hospital setting?
Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care
Year: 2014
Outcomes and characteristics of COVID-19 patients treated with CPAP/ HFNO outside of the Intensive Care setting
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021
COPD detected with screening: Impact on patient management and prognosis
Source: International Congress 2014 – Diagnosing and managing asthma and COPD in primary care
Year: 2014
Perioperative management of patients with Pulmonary Hypertension undergoing Non-Cardiac Surgery: A Systemic Review and UK Consensus Statement
Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension
Year: 2020
Differences in pulmonary rehabilitation outcomes in patients after single or double lung transplantation
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2
Year: 2014
Greater Glasgow Health Board COPD Outreach Spirometry: are the patients referred on appropriate or optimal therapy?
Source: Eur Respir J 2006; 28: Suppl. 50, 282s
Year: 2006
An Audit of Hospital in the Home Treatment in Respiratory Patients
Source: Virtual Congress 2021 – Pneumonia
Year: 2021
A cohort evaluation of WHO class II and IV TB patients treated at the National Institute of Respiratory Diseases (INER)
Source: Eur Respir J 2001; 18: Suppl. 33, 474s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept